Page last updated: 2024-09-04

chamaejasmine and Cancer of Larynx

chamaejasmine has been researched along with Cancer of Larynx in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jin, D; Liu, Y; Tian, L; Wang, Y; Zhao, Y	1

Other Studies

1 other study(ies) available for chamaejasmine and Cancer of Larynx

Article	Year
Chamaejasmine inactivates Akt to trigger apoptosis in human HEp-2 larynx carcinoma cells. Molecules (Basel, Switzerland), 2011, Sep-27, Volume: 16, Issue:10 Topics: Animals; Antineoplastic Agents, Phytogenic; Apigenin; Apoptosis; bcl-Associated Death Protein; Biflavonoids; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Survival; Female; Glycogen Synthase Kinase 3; HEK293 Cells; Humans; Laryngeal Neoplasms; Mice; Mice, Nude; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Signal Transduction	2011

Article

Year

Chamaejasmine inactivates Akt to trigger apoptosis in human HEp-2 larynx carcinoma cells.

Molecules (Basel, Switzerland), 2011, Sep-27, Volume: 16, Issue:10

Topics: Animals; Antineoplastic Agents, Phytogenic; Apigenin; Apoptosis; bcl-Associated Death Protein; Biflavonoids; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Survival; Female; Glycogen Synthase Kinase 3; HEK293 Cells; Humans; Laryngeal Neoplasms; Mice; Mice, Nude; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Signal Transduction

2011